Key result
Baseline creatinine <110 μmol/L linked to ~16% higher major cardiovascular events risk in post-PCI AMI patients.
Why the study?
The study evaluated the correlation between creatinine levels and post-PCI adverse events, aiming to clarify potential correlation thresholds and independent predictive value.
Does baseline serum creatinine level predict the risk of major adverse events (MACE, NACE, MACCE) in patients with acute myocardial infarction after percutaneous coronary intervention?
Cohort (n=3,878)
Yes
Does baseline serum creatinine level predict the risk of major adverse events (MACE, NACE, MACCE) in patients with acute myocardial infarction after percutaneous coronary intervention?
There is a J-shaped correlation between baseline creatinine levels and adverse events post-PCI, with levels below 110 μmol/L paradoxically associated with increased risk, suggesting it as a key threshold for risk stratification.
Answers are grounded in this paper and cite their sources.
Suggests low baseline creatinine may paradoxically predict higher MACE risk post-PCI; leaves open whether.
Background and aims To evaluate the correlation between creatinine (Cre) level and the risk of three kinds of adverse events in patients after percutaneous coronary intervention (PCI), and to clarify its potential correlation threshold and independent predictive value. Methods and results This investigation was designed as a retrospective cohort analysis, encompassing 3, 878 individuals diagnosed with acute myocardial infarction who received PCI between January 2018 and December 2020. The primary outcomes were three types of adverse events that occurred post-procedure. To explore the relationship between Cre levels and the outcome measures, a restricted cubic spline model was employed, while the Cox proportional hazards regression model assessed the independent predictive significance. There were 996 instances (25.7%) of adverse events reported. The evaluation using a restricted cubic spline model revealed a notable J-shaped relationship between creatinine levels and the likelihood of three types of adverse events following PCI (nonlinear P < 0.05), with the inflection point identified at 110 μmol/L. When considering Cre=110 μmol/L as the baseline, patients with Cre levels below this threshold (low value group) exhibited a 15.5% increase in MACE risk (95% CI: 1.006-1.327, P = 0.0416), a 15.6% increase in NACE risk (95% CI: 1.004-1.330, P = 0.0436) and a 16.1% increase in MACCE risk (95% CI: 1.015-1.329, P = 0.0301). Conclusion There is a J-shaped correlation between Cre level and the risk of three kinds of adverse events in patients after PCI, and the inflection point of 110 μmol/L can be used as the key threshold for clinical risk stratification and individualized intervention.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) conducted a cohort in Acute myocardial infarction post-percutaneous coronary intervention (n=3,878). Creatinine levels < 110 mmol/L vs. Creatinine level of 110 mmol/L was evaluated on Major adverse cardiovascular events (MACE) (HR 1.155, 95% CI 1.006-1.327, p=0.0416). Baseline creatinine levels below 110 mmol/L were associated with a 15.5% increased risk of major adverse cardiovascular events in patients with acute myocardial infarction post-PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: